WHO recommends 'life-saving' IL-6 inhibitors for severe COVID-19

Retrieved on: 2021-07-07 11:26:15

Tags for this article:

Immunosuppressants

Medical specialties

Click the tags to see associated articles and topics

WHO recommends 'life-saving' IL-6 inhibitors for severe COVID-19. View article details on HISWAI: http://www.pmlive.com/pharma_news/who_recommends_life-saving_il-6_inhibitors_for_severe_covid-19_1372815

Excerpt

WHO's updated patient care guidelines now include Roche's Actemra (tocilizumab) and Sanofi's Kevzara (sarilumab) for the treatment of patients who ...

Article found on: www.pmlive.com

View Original Article